The estimated Net Worth of Joseph J. Stich is at least $5.92 Milion dollars as of 21 August 2024. Mr. Stich owns over 21,285 units of Surmodics stock worth over $3,271,978 and over the last 15 years he sold SRDX stock worth over $1,953,794. In addition, he makes $696,127 as Vice President a General Manager - In Vitro Diagnostics at Surmodics.
Joseph has made over 42 trades of the Surmodics stock since 2014, according to the Form 4 filled with the SEC. Most recently he exercised 21,285 units of SRDX stock worth $706,662 on 21 August 2024.
The largest trade he's ever made was exercising 27,548 units of Surmodics stock on 22 August 2016 worth over $254,819. On average, Joseph trades about 3,258 units every 57 days since 2010. As of 21 August 2024 he still owns at least 83,405 units of Surmodics stock.
You can see the complete history of Mr. Stich stock trades at the bottom of the page.
Joseph J. Stich serves as Vice President, General Manager - In Vitro Diagnostics of the Company. He joined the Company in March 2010 as Vice President of Marketing, Corporate Development and Strategy. In August 2011, he became Vice President, Business Operations and General Manager, In Vitro Diagnostics and in September 2013 his role was adjusted to Vice President and General Manager, In Vitro Diagnostics. Before joining Surmodics, Mr. Stich was Vice President of Corporate Development for Abraxis BioScience, LLC, a biotechnology company focused on oncology therapeutics, from 2009 to 2010. Prior to joining Abraxis, he was a Vice President for MGI Pharma, Inc., a biopharmaceutical company, from 2005 to 2009. Mr. Stich’s prior experience also includes serving as President/COO of Pharmaceutical Corp. of America (a subsidiary of Publicis Healthcare Specialty Group), and positions of increasing responsibility in sales and marketing at Sanofi-Aventis Pharmaceuticals. He received a B.B.A. degree from the University of Wisconsin — Whitewater in 1988, and an M.B.A. degree from Rockhurst University in Kansas City, Missouri in 1996.
As the Vice President a General Manager - In Vitro Diagnostics of Surmodics, the total compensation of Joseph Stich at Surmodics is $696,127. There are 7 executives at Surmodics getting paid more, with Gary Maharaj having the highest compensation of $2,343,630.
Joseph Stich is 54, he's been the Vice President a General Manager - In Vitro Diagnostics of Surmodics since 2013. There are 14 older and 5 younger executives at Surmodics. The oldest executive at Surmodics, Inc. is David Dantzker, 76, who is the Independent Director.
Joseph's mailing address filed with the SEC is 9924, West 74th Street, Eden Prairie, Hennepin County, Minnesota, 55344, United States of America.
Over the last 21 years, insiders at Surmodics have traded over $26,204,565 worth of Surmodics stock and bought 19,725 units worth $436,251 . The most active insiders traders include Jeffrey C Smith, Gary R Maharaj a Value Lp Starboard Value Gp.... On average, Surmodics executives and independent directors trade stock every 34 days with the average trade being worth of $415,014. The most recent stock trade was executed by Joseph J. Stich on 21 August 2024, trading 21,285 units of SRDX stock currently worth $706,662.
surmodics partners with the world's leading and emerging medical device, diagnostic and life sciences companies to develop and commercialize innovative products designed to improve lives by enabling the detection and treatment of disease. following two recent acquisitions, the company is transforming its medical device business from being a provider of coating technologies, to offering whole-product solutions. throughout its transformation, surmodics’ mission remains: to improve the detection and treatment of disease by using our technology to provide solutions to difficult medical device and diagnostic challenges.
Surmodics executives and other stock owners filed with the SEC include: